{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:18:26Z","timestamp":1792189106342,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ygyno.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T17:16:45Z","timestamp":1684516605000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma"],"prefix":"10.1016","volume":"174","author":[{"given":"Alexandra Maria","family":"Knipprath-M\u00e9sz\u00e1ros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annkathrin","family":"Butensch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertina","family":"Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schoetzau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Montavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Heinzelmann-Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolin","family":"Manegold-Brauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2023.05.005_bb0005","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine myomas","volume":"369","author":"Bulun","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0010","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.grf.0000159538.27221.8c","article-title":"Role, epidemiology, and natural history of benign uterine mass lesions","volume":"48","author":"Ryan","year":"2005","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"Amant","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0025","series-title":"Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication","author":"Safety Communications","year":"2014"},{"issue":"98","key":"10.1016\/j.ygyno.2023.05.005_bb0030","first-page":"e1","article-title":"Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation","volume":"214","author":"Harris","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0035","doi-asserted-by":"crossref","first-page":"179.e1","DOI":"10.1016\/j.ajog.2018.11.1086","article-title":"Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study","author":"Multinu","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0040","article-title":"FDA takes new steps to increase the safety of laparascopic power morcellators when used in gynecologic surgeries: FDA safety communication","author":"Shuren","year":"2020","journal-title":"Food Drug Administr."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0045","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/aogs.13008","article-title":"Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study","volume":"95","author":"Skorstad","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.005_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000080283","article-title":"Preoperative in 106 patients with uterine sarcoma in Hokkaido, Japan","volume":"67","author":"Sagae","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jog.13792","article-title":"Diagnostic value of combination serum assay of lactate dehydrogenase, D-dimer, and C-reactive protein for uterine leiomyosarcoma","volume":"45","author":"Nishigaya","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12885-020-07003-z","article-title":"Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jcu.20075","article-title":"Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings","volume":"33","author":"Aviram","year":"2005","journal-title":"J. Clin. Ultrasound"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jcu.20386","article-title":"Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?","volume":"35","author":"Exacoustos","year":"2007","journal-title":"J. Clin. Ultrasound"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0075","first-page":"29","article-title":"Color Doppler ultrasonography in the differentiation of uterine sarcomas from uterine leiomyomas","volume":"23","author":"Szab\u00f3","year":"2002","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.05.005_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.6118\/jmm.19007","article-title":"Sonographic and clinical characteristics of uterine sarcoma initially misdiagnosed as uterine fibroid in women in the late reproductive age","volume":"25","author":"Kim","year":"2019","journal-title":"J. Menopausal. Med."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/uog.20270","article-title":"Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma","volume":"54","author":"Ludovisi","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0090","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S1470-2045(15)00375-7","article-title":"Morcellation of uterine leiomyomas: a plea for patient triage","volume":"16","author":"Amant","year":"2015","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2023.05.005_bb0095","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/cancers14081966","article-title":"Preoperative differentiation of uterine leiomyomas and leiomyosarcomas: current possibilities and future directions","volume":"14","author":"Zak","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12885-020-07003-z","article-title":"Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0105","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00404-019-05344-0","article-title":"Benign uterine mass-discrimination from leiomyosarcoma by a preoperative risk score: a multicenter cohort study","volume":"300","author":"K\u00f6hler","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0110","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s00330-013-2819-9","article-title":"How to differentiate benign from malignant myometrial tumours using MR imaging","volume":"23","author":"Thomassin-Naggara","year":"2013","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s00261-014-0324-5","article-title":"Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density","volume":"40","author":"Tasaki","year":"2015","journal-title":"Abdom. Imaging"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/RCT.0000000000000565","article-title":"Diffusion-weighted imaging for differentiating uterine Leiomyosarcoma from degenerated leiomyoma","volume":"41","author":"Li","year":"2017","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0125","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1007\/s00330-009-1471-x","article-title":"Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas","volume":"19","author":"Namimoto","year":"2009","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0130","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MNM.0000000000000612","article-title":"Diffusion-weighted MRI and 18F-FDG-PET\/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature","volume":"38","author":"Dubreuil","year":"2017","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/healthcare7040158","article-title":"Differential diagnosis of uterine leiomyoma and uterine sarcoma using magnetic resonance images: a literature review","volume":"7","author":"Suzuki","year":"2019","journal-title":"Healthcare"},{"issue":"368","key":"10.1016\/j.ygyno.2023.05.005_bb0140","first-page":"e1","article-title":"Clinical application of diffusionweighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma","volume":"210","author":"Sato","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0145","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.clinimag.2014.06.004","article-title":"Magnetic resonance and diffusionweighted imaging in categorization of uterine sarcomas: correlation with pathological findings","volume":"38","author":"Zhang","year":"2014","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0150","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1007\/s00261-019-02097-x","article-title":"T2 hyperintense myometrial tumors: can MRI features diferentiate leiomyomas from leiomyosarcomas?","volume":"44","author":"Rio","year":"2019","journal-title":"Abdom Radiol. (NY)."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0155","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1007\/s00330-016-4623-9","article-title":"Diferentiation of uterine Leiomyosarcoma from atypical leiomyoma: diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis","volume":"27","author":"Lakhman","year":"2017","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0160","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1007\/s00261-021-03132-6","article-title":"Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system","volume":"46","author":"Jagannathan","year":"2021","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/2193-1801-3-678","article-title":"Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass","volume":"3","author":"Nagai","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0170","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s40064-015-1318-7","article-title":"Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass","volume":"4","author":"Nagai","year":"2015","journal-title":"SpringerPlus"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1525-1438.2002.01086.x","article-title":"Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus","volume":"12","author":"Goto","year":"2002","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0180","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.acra.2018.01.002","article-title":"Utility of clinical parameters and multiparametric MRI as predictive factors for differentiating uterine sarcoma from atypical leiomyoma","volume":"25","author":"Qiu Bi","year":"2018","journal-title":"Acad. Radiol."},{"issue":"8","key":"10.1016\/j.ygyno.2023.05.005_bb0185","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/cancers14081966","article-title":"Preoperative differentiation of uterine leiomyomas and leiomyosarcomas: current possibilities and future directions","volume":"14","author":"Zak","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/diagnostics13030501","article-title":"How frequently benign uterine myomas appear suspicious for sarcoma as assessed by transvaginal ultrasound?","volume":"13","author":"Cabezas","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0195","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","article-title":"International ovarian tumor analysis (IOTA) group. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the international ovarian tumor analysis (IOTA) group","volume":"16","author":"Timmerman","year":"2000","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0200","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/uog.18909","article-title":"Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study","volume":"51","author":"Epstein","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/uog.14806","article-title":"Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the morphological uterus sonographic assessment (MUSA) group","volume":"46","author":"Van den Bosch","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0215","author":"R Core Team"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0225","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/uog.21968","article-title":"Imaging in gynecological disease: clinical and ultrasound features of extragastrointestinal stromal tumors (GIST)","volume":"56","author":"Ambrosio","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2010.05.011","article-title":"Short-term change in growth of uterine leiomyoma: tumor growth spurts","volume":"95","author":"Baird","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0235","first-page":"3","article-title":"Natural history of uterine polyps and leiomyomata","volume":"100","author":"DeWaay","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0240","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0245","first-page":"1289","article-title":"Transient rapid growth of uterine leiomyoma in a postmenopausal woman","volume":"6","author":"Kawamura","year":"1999","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0250","first-page":"414","article-title":"Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma","volume":"83","author":"Parker","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00404-018-4949-4","article-title":"Incidence and groups at risk for unexpected uterine leiomyosarcoma: a Dutch nationwide cohort study","volume":"299","author":"van den Haak","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejogrb.2022.01.013","article-title":"Preoperative clinical characteristics between uterine sarcoma and leiomyoma in patients with uterine mass, a case-control study","volume":"270","author":"Chantasartrassamee","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0265","doi-asserted-by":"crossref","DOI":"10.4293\/JSLS.2017.00066","article-title":"Clinical characteristics differentiating uterine sarcoma and fibroids","volume":"22","author":"Chen","year":"2018","journal-title":"JSLS."},{"key":"10.1016\/j.ygyno.2023.05.005_bb0270","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IGC.0000000000000911","article-title":"European society of gynecological oncology statement on fibroid and uterine Morcellation","volume":"27","author":"Halaska","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2023.05.005_bb0275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823002147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823002147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:52:43Z","timestamp":1715820763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":54,"alternative-id":["S0090825823002147"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.05.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High negative prediction for the Basel sarcoma score: Sonographic assessment of features suspicious of uterine sarcoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}